These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1474279)

  • 41. A comparative study of the efficacy of WHO and IAL multidrug therapy regimens for leprosy--an in-vivo and in-vitro study.
    Revankar CR; Mahadevan PR; Ganapati R
    Indian J Lepr; 1986; 58(4):543-8. PubMed ID: 3553361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice.
    Xiong JH; Ji B; Perani EG; Pétinon C; Grosset JH
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):37-42. PubMed ID: 8189087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of New Antibacterial Drugs and their Combinations in a Murine Model to Identify Short Duration Alternative Chemotherapy for Leprosy.
    Arumugam S; Joseph P; Ponnaiya J; Richard J; Das M; Chaitanya VS; Ebenezer M
    Indian J Lepr; 2016; 88(3):159-76. PubMed ID: 30207441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multiplication of Mycobacterium leprae in the nude mouse, and some applications of nude mice to experimental leprosy.
    McDermott-Lancaster RD; Ito T; Kohsaka K; Guelpa-Lauras CC; Grosset JH
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):889-95. PubMed ID: 3325583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antileprosy activity of some dialkyldithiocarbamates.
    Makarov V; Riabova OB; Yuschenko A; Urlyapova N; Daudova A; Zipfel PF; Möllmann U
    J Antimicrob Chemother; 2006 Jun; 57(6):1134-8. PubMed ID: 16595643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

  • 48. A comparative study of four rodent systems to monitor initial therapy of lepromatous leprosy: in search of a more sensitive system to assess bacterial viability.
    Gelber RH; Humphres RC; Fieldstell AH
    Acta Leprol; 1984; 2(2-4):319-25. PubMed ID: 6398591
    [No Abstract]   [Full Text] [Related]  

  • 49. Activity of combinations of dapsone, rifampin, minocycline, clarithromycin, and sparfloxacin against M. leprae-infected mice.
    Gelber RH; Siu P; Tsang M; Richard V; Chehl SK; Murray LP
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):259-64. PubMed ID: 7602221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR; Pai VV; Samy MS; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract]   [Full Text] [Related]  

  • 51. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
    Sousa AL; Stefani MM; Pereira GA; Costa MB; Rebello PF; Gomes MK; Narahashi K; Gillis TP; Krahenbuhl JL; Martelli CM
    Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single dose multidrug therapy for single lesion paucibacillry leprosy.
    Salafia A
    Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of five treatment regimens, using either dapsone monotherapy or several doses of rifampicin in the treatment of paucibacillary leprosy.
    Pattyn SR; Husser JA; Baquillon G; Maiga M; Jamet P
    Lepr Rev; 1990 Jun; 61(2):151-6. PubMed ID: 2198414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimal inhibitory dosage of rifampicin in intermittent treatment of Mycobacterium leprae infection in mice.
    Pattyn SR; Saerens EJ
    Zentralbl Bakteriol Orig A; 1975 May; 231(4):503-7. PubMed ID: 1101580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA; Gardner GD
    Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single dose ROM therapy in Goa.
    Shukla P; Miranda MS; Prabhudesai R; Rege VL
    Indian J Lepr; 2002; 74(2):169-72. PubMed ID: 12708738
    [No Abstract]   [Full Text] [Related]  

  • 58. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 59. How much non-infectious are the "non-infectious" lepromatous leprosy patients?
    Prabhakar MC; Appa Rao AV; Krishna DR; Ramanakar TV
    Lepr India; 1983 Jul; 55(3):576-83. PubMed ID: 6361383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The activity of amoxicillin plus clavulanic acid against Mycobacterium leprae in mice.
    Gelber RH
    J Infect Dis; 1991 Jun; 163(6):1374-7. PubMed ID: 2037803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.